| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | $0.0B | $0.0B | $0.0B | $0.0B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.0B | $-0.0B | $-0.3B | $-0.1B | $0.0B | $0.0B | $-0.0B |
| EPS (Basic) | $1.24 | $0.57 | $-0.89 | $-6.90 | — | — | $0.29 | $-0.52 |
| EPS (Diluted) | — | — | — | — | — | $0.23 | $0.29 | $-0.52 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.7B | $5.7B | $4.3B | $3.9B | $7.1B | $4.1B | $3.9B | $3.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.7B | $0.3B | $0.2B | $0.2B | $0.4B | $0.2B | $0.2B | $0.1B |
| Total Liabilities | $10.3B | $5.1B | $3.8B | $3.4B | $6.3B | $3.6B | $3.5B | $3.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.4B | $0.7B | $0.5B | $0.4B | $0.8B | $0.4B | $0.4B | $0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.0B | $0.3B | $0.1B | $0.1B | — | — |
| Investing Cash Flow | $-5.4B | $-1.4B | $-0.4B | $2.4B | $-3.0B | $-0.2B | — | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $5.6B | $1.5B | $0.4B | $-2.9B | $3.1B | $0.2B | — | — |